Retatrutide is a newly developed medication that acts as a potent GLP-1 receptor activator. This innovative method holds significant hope for controlling type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide boosts insulin secretion and limits glucagon release, leading to improved glucose control. Clinical trials have demonstrated